What is the share price of AGS Health Ltd?

Company share prices are keep on changing according to the market conditions. The current trading price of AGS Health Ltd on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of AGS Health?

The latest standalone P/E ratio of AGS Health as of 01-Jan-1970 is 0.00.

What is the P/B ratio of AGS Health Ltd?

The latest standalone P/B ratio of AGS Health Ltd as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of AGS Health Ltd?

The 52-week high of AGS Health Ltd is Rs. and the 52-week low is Rs. .

AGS Health Ltd

Name: AGS Health Ltd
Brand: AGS Health

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: BPO/ITeS | Small Cap | AGS Health Share Price

BSE Share Price
Not Listed

AGS Health Ltd

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: BPO/ITeS | Small Cap | AGS Health Share Price

BSE Share Price
Not Listed

Key Metrics

Valuation Multiples

Market Cap

₹0 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹0

TTM Sales

₹320 Cr.

Book Value per Share

P/E Ratio

0.00

Industry PE

22.5

Price to Book (P/B)

0.00

Price to Sales (P/S)

0.00

EV/EBITDA

0.00

Dividend Yield

NAN%

Profitability Efficiency

Return on Equity (ROE)

7.04%

Return on Capital Employed (ROCE)

9.67%

Return on Assets (ROA)

6.07%

Operating Profit Margin

28.9%

Net Profit Margin

12.85%

Gross Profit Margin

31.9%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

18.65%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

30.42%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

27.47%

Asset Quality

Promoter Holding

Pledged shares (%) of Promoter's holding (%)

Reserves

₹72 Cr.

Equity

₹0 Cr.

Face Value

All Time Low / High

- / -

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26	TTM
ROCE % ⓘ	89.4%	149.6%	91.6%	40.7%	29.9%	35.4%	36.4%	35.2%	34.5%	9.7%	-
Growth Parameters ⓘ
Sales ⓘ	304	320	320	406	382	591	782	989	1,195	1,418	320
Sales YoY Gr.	-	5.1%	-0.1%	27%	-5.8%	54.7%	32.2%	26.5%	20.8%	18.7%	-
Adj EPS ⓘ	2.6	1.6	3.3	2.2	2.3	3.1	4	5.8	9.1	6.9	0
YoY Gr.	-	-36.8%	99.4%	-31.4%	1.8%	37.4%	28.5%	44.6%	56.4%	-24.5%	-
BVPS (₹) ⓘ	5.8	3.6	7.1	8.8	11.5	14.8	19.1	24.7	31.6	116.2	0
Adj Net Profit ⓘ	53.3	33.8	67.3	46.1	46.9	64.6	82.9	120	188	266	NAN
Cash Flow from Ops. ⓘ	39.4	-58.7	-0.7	60.8	25.6	74.7	25.8	116	213	159	-
Debt/CF from Ops. ⓘ	0	-0	0	0	0	0	0	0	0	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	18.6%	30%	22%	18.7%
Adj EPS ⓘ	11.5%	24.7%	19.5%	-24.5%
BVPSⓘ	39.6%	58.7%	82.6%	267.6%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26	TTM
Return on Equity % ⓘ	59.2	34.9	61.2	28	22.3	23.7	23.7	26.5	32.2	10.3	0
Op. Profit Mgn % ⓘ	30.2	26.5	17.8	16.6	17.3	19.1	18.5	21.2	26.3	28.9	NAN
Net Profit Mgn % ⓘ	17.5	10.6	21.1	11.4	12.3	10.9	10.6	12.1	15.7	18.8	NAN
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	-
Working Cap Days ⓘ	96	89	118	141	187	147	150	157	153	148	0
Cash Conv. Cycle ⓘ	51	47	45	67	104	90	101	105	104	106	0

Valuation of AGS Health - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Financials

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Sales	304.45	319.97	319.64	405.83	382.19	591.09	781.65	988.97	1,194.89	1,417.77
Operating Expenses > ⓘ +	212.66	235.28	263.18	338.56	316.27	478.03	637.33	779.66	880.86	1,008.20
Manufacturing Costs	20.83	17.24	18.04	27.95	12.80	20.71	23.15	45.70	48.61	76.29
Material Costs	0	0	0	0	0	0	0	0	0	0
Employee Cost	162.29	182.87	206.27	271.20	255.28	402.19	513.58	621.80	720.62	831.33
Other Costs > ⓘ	29.55	35.18	38.86	39.41	48.19	55.14	100.61	112.17	111.63	100.58
Operating Profit > ⓘ	91.79	84.68	56.46	67.27	65.92	113.06	144.32	209.30	314.03	409.57
Operating Profit Margin (%)	30.1%	26.5%	17.7%	16.6%	17.2%	19.1%	18.5%	21.2%	26.3%	28.9%
Other Income > ⓘ +	0.92	9.03	53.22	7.46	5.50	7.79	18.87	8.04	17.74	57.27
Exceptional Items > ⓘ	0	61.89	0	0	0	0	0	-11.39	-77.36	-158.66
Interest > ⓘ	1.53	0.55	0.44	0.04	0.93	4.34	6.10	7.53	12.07	14.23
Depreciation > ⓘ	9.72	10.22	8.79	7.79	8.36	24.64	35.98	46.35	53.57	57.75
Profit Before Tax > ⓘ	81.45	144.83	100.45	66.90	62.14	91.87	121.10	152.07	188.77	236.21
Tax > ⓘ	27.79	67.72	33.12	16.90	14.99	23.62	30.27	36.43	45.84	54.01
Profit After Tax	53.67	77.11	67.33	50	47.15	68.25	90.83	115.64	142.93	182.20
PAT Margin (%)	17.6%	24.1%	21.1%	12.3%	12.3%	11.6%	11.6%	11.7%	12.0%	12.9%
Adjusted EPS (₹)	2.6	3.7	3.3	2.4	2.3	3.3	4.4	5.6	6.9	4.7
Dividend Payout Ratio (%)	0%	120.50%	0%	0%	0%	0%	0%	0%	0%	0%

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Equity and Liabilities
Shareholders Fund +	119.79	73.78	146.31	182.85	238.50	305.69	394.29	511.62	653.61	4,521.84
Share Capital ⓘ	1.72	1.72	1.72	1.72	1.72	1.72	1.72	1.72	1.72	38.92
Reserves ⓘ	118.07	72.06	144.58	181.13	236.78	303.97	392.56	509.90	651.88	4,482.93
Debt +	0.32	0.22	0	0	0	0	0	0	0	0
Long Term Debt	0.32	0.22	0	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	7.76	7.64	11.46	13.49	17.75	24.86	37.13	53.48	58.55	69.39
Others Liabilities ⓘ	21.74	24.87	22.83	60.46	72.40	141.66	171.88	204.87	341.97	359.22
Total Liabilities ⓘ	149.61	106.52	180.60	256.80	328.66	472.21	603.30	769.98	1,054.12	4,950.45
Fixed Assets
Net Fixed Assets ⓘ +	29.92	23.57	16.56	20.74	21.16	105.86	141.74	170.65	215.72	232.75
Gross Block	52.13	56	57.04	66.26	74.87	130.50	191.01	242.89	321.72	361.32
Accumulated Depreciation	22.21	32.43	40.48	45.52	53.71	24.64	49.27	72.24	106	128.57
CWIP ⓘ	0.03	0.78	0.15	0.11	0.93	3.78	1.30	3.08	3.78	0.68
Investments ⓘ	20.47	0	0	0	0	0	0	88.38	208.32	3,966.19
Inventories	0	0	0	0	0	0	0	0	0	0
Trade Receivables	66.88	37.12	67.22	113.91	146.40	201.09	313.65	376.68	462.60	546.41
Cash Equivalents	2.83	21.80	18.13	67.60	84.29	107.78	73.51	46.31	87.70	138.83
Others Assets ⓘ	29.48	23.25	78.54	54.43	75.88	53.69	73.09	84.88	76	65.59
Total Assets ⓘ	149.61	106.52	180.60	256.80	328.66	472.21	603.30	769.98	1,054.12	4,950.45

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Cash Flow From Operating Activity ⓘ +	39.42	-58.74	-0.65	60.79	25.57	74.65	25.84	116.28	212.72	158.60
PBT ⓘ	81.45	144.83	100.45	66.90	62.14	91.87	121.10	152.07	188.77	236.21
Adjustment ⓘ	10.29	-163.95	11.06	4.70	11.45	27.13	34.36	61.02	129.44	139.62
Changes in Working Capital ⓘ	-24.91	27.84	-70.64	7.94	-35.53	-15.06	-93.76	-54.52	-55.55	-159.72
Tax Paid ⓘ	-27.42	-67.47	-41.52	-18.74	-12.48	-29.29	-35.87	-42.30	-49.94	-57.51
Cash Flow From Investing Activity ⓘ +	-40.35	190.70	-12.66	-10.92	-19.04	-37.48	-39.55	-122.11	-175.92	-3,861.43
Capex	-21.63	-4.94	-2.72	-10.94	-8.30	-29.13	-40.36	-36.39	-35.74	-48.16
Net Investments	0	20.56	-9.98	0	-10.40	0	3.28	-86.79	-141.80	-3,815.11
Others ⓘ	-18.73	175.08	0.05	0.02	-0.34	-8.35	-2.47	1.07	1.61	1.84
Cash Flow From Financing Activity ⓘ +	-4.65	-111.99	-0.34	-0.40	-0.24	-12.42	-17.28	-21.66	-27.24	3,683.05
Net Proceeds from Shares ⓘ	0.02	0.01	0	0	0	0	0	0	0	3,715.04
Net Proceeds from Borrowing ⓘ	0	-0.12	-0.32	0	0	0	0	0	0	0
Interest Paid ⓘ	-0.09	-0.04	-0.02	-0.40	-0.24	0	0	0	0	0
Dividend Paid ⓘ	0	-92.92	0	0	0	0	0	0	0	0
Others ⓘ	-4.59	-18.92	0	0	0	-12.42	-17.28	-21.66	-27.24	-31.98
Net Cash Flow ⓘ	-5.58	19.96	-13.65	49.47	6.29	24.74	-30.99	-27.49	9.55	-19.78

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Ratios
ROE (%)	59.61	79.67	61.18	30.38	22.38	25.08	25.95	25.53	24.53	7.04
ROCE (%)	89.44	149.62	91.55	40.67	29.93	35.36	36.35	35.24	34.47	9.67
Asset Turnover Ratio	2.54	2.5	2.23	1.86	1.31	1.48	1.45	1.44	1.31	0.47
PAT to CFO Conversion(x)	0.73	-0.76	-0.01	1.22	0.54	1.09	0.28	1.01	1.49	0.87
Working Capital Days
Receivable Days	64.90	59.30	59.60	81.50	124.30	107.30	120.20	127.40	128.20	129.90
Inventory Days	0	0	0	0	0	0	0	0	0	0
Payable Days	0	0	0	0	0	0	0	0	0	0

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

AGS Health Ltd FAQs

The current trading price of AGS Health on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of AGS Health stood at ₹0.00 Cr

The latest P/E ratio of AGS Health as of 31-Dec-1969 is 0.00.

The latest P/B ratio of AGS Health as of 31-Dec-1969 is 0.00.

The 52-week high of AGS Health is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of AGS Health is ₹320 ( Cr.) .

Data is not available for this company.

No data found

About AGS Health Ltd

No data to display

You have 4 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

AGS Health Ltd

AGS Health Ltd

10 Year X-Ray :